Skip to main content

News

Explore the latest stories and publications from NCATS and our partners, see upcoming events, or explore the variety of resources we provide to better understand translational science and our work.

News

Read the latest news from NCATS and its collaborators whose research is supported through the Center’s programs, or follow coverage of NCATS' translational research activities through national and local media.

Reconstructing the Path of a Seizure

December 3, 2024 - Grantee/Partner News

  • Clinical and Translational Science Awards (CTSA) Program

Spectradyne: SBIR Funding Spurs Advances in Nanoparticle Technology

November 19, 2024 - NCATS News

  • Small Business (SBIR)

NCATS small business innovation research funding helped Spectradyne, LLC, commercialize an improved nanoparticle analyzer critical to research and drug development.

New Path for a Gene Therapy Trial at NIH for a Rare Metabolic Disease

November 19, 2024 - NCATS News

  • Bespoke Gene Therapy Consortium (BGTC)
  • Our Impact on Clinical Trials
  • Our Impact on Drug Discovery and Development
  • Our Impact on Rare Diseases
  • Platform Vector Gene Therapy (PaVe-GT)

Scientists at NCATS and other NIH institutes and centers are teaming up to advance a gene therapy treatment for MMA, a rare and potentially life-threatening genetic disorder.

Study Identifies Strategy for AI Cost-Efficiency in Health Care Settings

November 18, 2024 - Grantee/Partner News

  • Clinical and Translational Science Awards (CTSA) Program

Azome Therapeutics Enters Into CRADA With National Center for Advancing Translational Sciences to Investigate Novel Inflammasome Antagonist to Prevent Bronchopulmonary Dysplasia

November 13, 2024 - Grantee/Partner News

  • Our Impact on Drug Discovery and Development

Why Is Asthma More Challenging for Arkansas Children? ACRI/UAMS Researcher Aims to Find Out With NIH Funding

November 13, 2024 - Grantee/Partner News

  • Clinical and Translational Science Awards (CTSA) Program

Last updated on June 13, 2024